Reproductive Firms Promote Polygenic Embryo Screening

Nucleus Genomics recently ran provocative New York City ads claiming polygenic embryo screening can predict traits such as height and intelligence, drawing public and expert scrutiny. Experts say PES, used only with IVF (about 2% of U.S. births) and costing roughly $2,500 per screened embryo, remains unproven since the first PES birth in 2020, raising accuracy, equity, and regulatory concerns.